Laurie Herviou

Centre National de la Recherche Scientifique

Also affiliated with Memorial Sloan Kettering Cancer Center, Institut de Génétique Humaine

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition”.

Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition

Blood(2020)10.1182/blood.2020008017

N/A

0DataRank · unranked

36 citations

Mandana T. Manzari, Laurie Herviou, Mariana Da Silva Ferreira, Connor J. Hagen, Hiroto Kiguchi +6 more

Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma

Clinical Epigenetics(2021)10.1186/s13148-021-01160-z

N/A

0DataRank · unranked

50 citations

Sara Ovejero, Fanny Izard, Ouissem Karmous-Gadacha, Claire Gourzonès, Céline Bellanger +10 more

Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy

Oncogenesis(2023)10.1038/s41389-023-00454-6

N/A

0DataRank · unranked

8 citations

Laurie Herviou, Yusuke Tsuda, Patricia Sung, Ziyu Xie, Eve Fishinevich +7 more